-Dennis E Hallahan Researcher Activity Profile

Research Author Detailed Information 

Dennis E Hallahan Publication Rate By Year

Dennis E Hallahan has published 4 paper(s) in 2006, 12 paper(s) in 2007, 1 paper(s) in 2008, for a total of 17 research publications in total.

Dennis E De Hallahan Author Information

LAST NAME: hallahan

FIRST NAME: Dennis E

INITIALS: de

AFFILIATION:

Papers

Dennis E Hallahan's Publication Record

1. Increased expression of nuclear factor E2 p45-related factor 2 (NRF2) in head and neck squamous cell carcinomas. Year Published: 2006
Department of Radiation Oncology, Vanderbilt University School of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee 37232, USA.
2. Noninvasive assessment of tumor vasculature response to radiation-mediated, vasculature-targeted therapy using quantified power Doppler sonography: implications for improvement of therapy schedules. Year Published: 2006
Department of Radiation Oncology, Vanderbilt University School of Medicine, 1301 22nd Ave S, B-902, Nashville, TN 37232, USA.
3. Lithium treatment prevents neurocognitive deficit resulting from cranial irradiation. Year Published: 2006
Department of Radiation Oncology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-5671, USA.
4. Histone deacetylase (HDAC) inhibitor LBH589 increases duration of gamma-H2AX foci and confines HDAC4 to the cytoplasm in irradiated non-small cell lung cancer. Year Published: 2006
Department of Radiation Oncology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
5. PDGFR-beta expression in small cell lung cancer patients. Year Published: 2007
Department of Medicine, Abington Memorial Hospital, Abington, PA, USA.
6. HIV protease inhibitors enhance the efficacy of irradiation. Year Published: 2007
Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
7. Histone deacetylase inhibitor NVP-LAQ824 sensitizes human nonsmall cell lung cancer to the cytotoxic effects of ionizing radiation. Year Published: 2007
Vanderbilt University School of Medicine, E1219 Medical Center North, 1161 21st Avenue South, Nashville, TN 37232, USA. kyle.cuneo@vanderbilt.edu
8. Impact of inhomogeneity corrections on dose coverage in the treatment of lung cancer using stereotactic body radiation therapy. Year Published: 2007
Department of Radiation Oncology, Vanderbilt University School of Medicine, Vanderbilt-Ingram Cancer Center, B-902, TVC, Preston Research Building, Nashville, Tennessee 37232-5671, USA. george.ding@vanderbilt.edu
9. A study on adaptive IMRT treatment planning using kV cone-beam CT. Year Published: 2007
Department of Radiation Oncology, Vanderbilt University, Nashville, TN, USA.
10. Molecular imaging of vascular endothelial growth factor receptor 2 expression using targeted contrast-enhanced high-frequency ultrasonography. Year Published: 2007
Department of Radiology and Radiological Sciences, Vanderbilt University Medical Center, CCC-1118 MCN, 1161 21st Ave, Nashville, TN 37232-2675, USA. andrej.lyshchik@vanderbilt.edu
11. Hedgehog signaling in the murine melanoma microenvironment. Year Published: 2007
Department of Radiation Oncology, Vanderbilt University School of Medicine, Nashville, USA, kyle.cuneo@vanderbilt.edu.
12. A study on adaptive IMRT treatment planning using kV cone-beam CT. Year Published: 2007
Department of Radiation Oncology, Vanderbilt University, Nashville, TN 37232-5671, USA. george.ding@vanderbilt.edu
13. Hedgehog signaling in the murine melanoma microenvironment. Year Published: 2007
Department of Radiation Oncology, Vanderbilt University School of Medicine, Nashville, USA.
14. A study on adaptive IMRT treatment planning using kV cone-beam CT. Year Published: 2007
Department of Radiation Oncology, Vanderbilt University, Nashville, TN 37232-5671, USA. george.ding@vanderbilt.edu
15. Molecular imaging of vascular endothelial growth factor receptor 2 expression using targeted contrast-enhanced high-frequency ultrasonography. Year Published: 2007
Department of Radiology and Radiological Sciences, Vanderbilt University Medical Center, CCC-1118 MCN, 1161 21st Ave, Nashville, TN 37232-2675, USA. andrej.lyshchik@vanderbilt.edu
16. Hedgehog signaling in the murine melanoma microenvironment. Year Published: 2007
Department of Radiation Oncology, Vanderbilt University School of Medicine, Nashville, USA.
17. Noninvasive assessment of cancer response to therapy. Year Published: 2008
Department of Radiation Oncology, School of Medicine, Vanderbilt University, 1301 22nd Avenue South, B902 TVC, Nashville, Tennessee 37232, USA.